1. Home
  2. PAVM

as of 03-27-2026 11:37am EST

$8.53
$0.41
-4.59%
Stocks Health Care Medical/Dental Instruments Nasdaq

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Founded: 2014 Country:
United States
United States
Employees: 107 City: NEW YORK
Market Cap: 9.1M IPO Year: N/A
Target Price: $510.00 AVG Volume (30 days): 13.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $0.21 - $28.44 Next Earning Date: 05-14-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): -96.97% Revenue Growth (next year): 450.56%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered PAVM Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 75.61%
75.61%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest PAVmed Inc. News

PAVM Breaking Stock News: Dive into PAVM Ticker-Specific Updates for Smart Investing

All PAVM News

Share on Social Networks: